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RotenoneRespiratory enzyme complex dysfunction is mechanistically involved in mitochondrial failure leading to
neurodegenerative disease, but the pathway is unclear. Here, age-related differences in mitochondrial
respiration were measured in both whole and permeabilized neurons from 9-month and 24-month adult rat
cortex cultured in common conditions. After permeabilization, respiration increased in both ages of neurons
with excess substrates. To dissect speciﬁc deﬁciencies in the respiratory chain, inhibitors for each respiratory
chain complex were used to isolate their contributions. Relative to neurons from 9-month rats, in neurons
isolated from 24-month rats, complexes I, III, and IV were more sensitive to selective inhibition. Flux control
point analysis identiﬁed complex I in neurons isolated from 24-month rats as the most sensitive to
endogenous substrate availability. The greatest age-related deﬁcit in ﬂux capacity occurred at complex IV
with a 29% decrease in neurons isolated from 24-month rats relative to those from 9-month rats. The deﬁcits
in complexes I and III may contribute to a redox shift in the quinone pool within the electron transport chain,
further extending these age-related deﬁcits. Together these changes could lead to an age-related
catastrophic decline in energy production and neuronal death.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
While neurodegeneration with age is widely documented as a
cause of disease [1], there are gaps in understanding of the
mechanisms behind it. Many potential pathways of energetic failure
have been considered [2]. Among these mechanisms are oxidation of
nucleic acids [3–6], calcium dysregulation [7–10], redox imbalance
[11–13], reactive oxygen species (ROS) attacks [14–16], and oxidative
phosphorylation deﬁcits [17–20]. Because the availability of energy
from oxidative phosphorylation is so critical to neuron function, here,
we investigated further the loss of oxidative phosphorylation by
controlling the substrate availability to neurons in situ.
Attempts to elucidate the chain of events leading to neurodegen-
eration with age have historically been limited by the lack of a viable
in situ model of mammalian aging. In homogenized brain tissue,
neurons are mixed with the aging environment of the brain, including
the aging vascular, hormonal, and immunological systems. Further-
more, brain homogenates do not provide an accurate model of
neurons attached to a substrate, forming synapses and transmitting
signals [21,22]. Isolated mitochondria risk considerable degradation
during the homogenization and isolation process, and are removed
from interaction with nuclear and cytoplasmic signaling [23–28].
Others have conducted studies in neurons isolated from embryonic+1 217 545 3227.
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ll rights reserved.[29] or very young (5–7 days) rats [30–33], precluding age-related
comparisons over the life-span. Our method of isolating whole
neurons from the brains of adult rats and growing them in common
culture conditions has allowed us to apply well-established techni-
ques to an improved model of mammalian aging [34,35]. Brewer [36]
showed that neurons cultured from different ages of rats demonstrate
distinct age-related susceptibility to lactate, glutamate, and beta-
amyloid. Live neurons isolated from the aging brain environment can
be monitored in their endogenous state [17], or permeabilized to
allow substrate control and pharmacologic isolation of complexes of
the electron transport chain [33].
Redox potential is a greatly under-appreciated source of energy
production in neuronal mitochondria [12,37,38]. Neurons isolated
from old rat brains consumemore redox active NADH and glutathione
than neurons frommiddle-age rat brains resulting in redox imbalance
with age, but the reason for increased consumption has not been
documented [12]. Furthermore, glutathione, part of the most
abundant redox pair responsible for redox buffering in the brain,
also acts as an antioxidant controlling reactive oxygen species
produced during oxidative phosphorylation. Other oxygen-consum-
ing enzymes in the brain such as cyclooxygenase, cytochrome P450,
heme oxygenase, lipoxygenase, NADPH oxidase, nitric oxide synthase,
phospholipase, and xanthine oxidase are also regulated by redox
balance. Reactive oxygen species (ROS) damage enzymes crucial to
energy production, and as a result of such damage can propagate
further ROS production. Damage to enzyme complexes involved in
oxidative phosphorylation is a documented result of excess ROS and
Table 1
Composition of pre-permeabilization medium and respiration medium developed by
Saﬁulina et al. [37].
Pre-permeabilization
medium
Respiration medium
Potassium methanesulfonate 81
BES 60
Mg2ATP 5.69
KOH 35
K-MES 100
Imidazole 20
MgCl2 1.38
HCl 16.25
BSA 5 mg/mL
K2EGTAa 7.23 7.23
CaK2EGTAa 2.77 2.77
Taurine 20 20
K2HPO4 3 3
Dithiothreitol 0.5 0.5
pH 7.1 7.1
Osmolarity 255 mOsm 225 mOsm
Concentrations given in mM unless otherwise noted.
a Free [Ca2+] in both media was 0.1 μM. K2EGTA and Ca2EGTA were made according
to Oroboros (www.oroboros.at, Innsbruck, Austria).
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been limited by their models [39,40]. ROS damage could affect the
inhibitor efﬁcacy for any complex by altering the number of binding
sites or their quality of binding.
In a previous study, we found that an age-related deﬁcit in
cytochrome C oxidase (complex IV) in whole cells at endogenous
levels of cytochrome c was not apparent in substrate-supplemented
submitochondrial particles, and that deﬁcits in cardiolipin and
upregulation of respiration in response to stress were corrected by
estrogen treatment [17]. In this study, we expanded our methods to
include substrate supplementation in whole cells, and we studied the
three upstream respiratory complexes, NADH-ubiquinone oxidore-
ductase (complex I), succinate dehydrogenase (complex II), and
cytochrome bc1 oxidoreductase (complex III).
2. Materials and methods
All reagents were purchased from Sigma Aldrich (St. Louis,
Missouri) unless otherwise noted.
2.1. Cell culture
Adult rat neurons were cultured according to the method of
Brewer [34,35]. Male Fisher 344 rats, which have a median life span of
24 months [41], were used for all experiments. The rats were fed rat
chow ad libitum and weighed 408+88 g (middle-age) or 403+77 g
(old) at the time of sacriﬁce. All animals were anesthetized with
isoﬂuorane prior to decapitation by guillotine. Cortical and hippo-
campal neurons were extracted from brains of middle-age (9 month)
and old (24 month) rats. Once dissected, the cortices were sliced to
0.5 mm with a McIlwain chopper (Campden Instruments, Lafayette,
IN), digested in 2 mg/mL papain (Worthington, Lakewood, NJ), and
triturated in Hibernate A/B27 (BrainBits, Springﬁeld, IL). Cells were
separated from debris on an Optiprep gradient and resuspended in
Neurobasal A/B27, 0.5 mM glutamine, 5 ng/mL basic human
recombinant FGF2 (Invitrogen, Carlsbad, CA). Cells were then plated
on poly-D-lysine-coated 15 mm glass cover slips (Assistent brand,
Carolina Biological, Burlington, NC) at a density of 500 cells/mm2 and
cultured at 37 °C, 5% CO2, 9% O2 for 7–12 days. Tomanually count cells,
each culture slip was photographed in 6 consecutive ﬁelds measuring
0.15 mm2 using 20×phase optics. Cell counts were used to normalize
respiration measurements. Each slip contained 37,700+4200 (mid-
dle-age, n= 44) or 33,390+ 4,100 (old, n= 37; p=0.47) neurons.
Slips were also photographed after respiration measurements to
conﬁrm the presence of cells.
2.2. Respiration in whole (non-permeabilized) cells
In order to measure respiration from a limited number of neurons
in their substrate-attached state, neuronal respiration before and after
addition of selective respiratory chain inhibitors was measured using
the Oxygraph-2K (Oroboros, Innsbruck, Austria). Two polarographic
oxygen sensors connected to temperature-controlled, continuously
stirred, sealed chambers measure oxygen concentration within the
chamber over time. Early experiments optimized 500 RPM as the best
stirring speed for full cell adherence in non-permeabilized cultures
with minimum electrode noise. DatLab4 software (Oroboros) cali-
brated the instrument using atmospheric oxygen concentration (21%)
and 0% oxygen concentration (obtained by addition of a few crystals
of sodium dithionite to water) as reference points.We derived oxygen
consumption rates from DatLab4-generated graphs of oxygen con-
centration and ﬂux in real time. Typical measurements in the
Oxygraph are taken from cell suspensions, but neuronal bioenergetics
rely on attachment to a substrate. We developed 14.5 mm diameter
stirbars, topped with silicone (Kwik-cast, World Precision Instru-
ments, Sarasota, FL) with Teﬂon star bases (Nalgene, Rochester, NY) toaccommodate placement of 15 mm diameter glass cover slips on
which neuronal cultures had adhered and grown. Complex I was
inhibited by rotenone [43,44], titrated in concentrations from 1 to
10 μM. To inhibit complex II, 3-nitropropionic acid [45,46] was titrated
in concentrations from 1 mM to 10 mM. To inhibit complex III,
antimycin A, [47] was titrated in concentrations from 0.1 μM to 1 μM,
diluted directly in Neurobasal A/B27 in a 1 mM stock and diluted
further in Neurobasal A/B27 to the necessary concentrations. To
inhibit complex IV, potassium cyanide [48] was titrated in concentra-
tions from 10 to 100 μM. For example, rotenone was diluted into
Neurobasal A/B27 from a 10mM stock in 100% ethanol and titrated in
concentrations from 1 to 10 μM in 2- to 5 -min increments using a
25 μL glass syringe with a 75 mm, 22-gauge needle (Hamilton, Reno,
NV). Each addition was 10 μL, 1/100 of the original volume, and
additive to the previous concentration. Prior experiments showed no
effect on respiration of using only the ethanol vehicle diluted in
Neurobasal A/B27 to 0.01%–0.1% (data not shown).
2.3. Bioenergetic assessment in permeabilized cells
K2EGTA and CaK2EGTA were made according to Oroboros (www.
oroboros.at, Innsbruck, Austria). Permeabilization and respiration
media were made according to Saﬁulina et al. [33] in Table 1. To
assess the minimum amount of time needed to permeabilize neurons
exposed to 50 μg/mL saponin, cells were incubated at room
temperature in permeabilization medium (Table 1) with the mem-
brane-impermeable nuclear stain propidium iodide (4.6 μg/mL).
Photographs of propidium iodide ﬂuorescence at 0, 1, 3, and
15 min. intervals were used to assess the time needed for
permeabilization. The following additions were made to the respira-
tion medium for each complex measurement: complex I: 5 mM
glutamate, 2 mM malate [33]; complex II: 10 mM succinate, 10 μM
rotenone [33,42]; complex III: 5 mM glutamate, 2 mMmalate, 10 mM
succinate [33,42]; complex IV: 0.5 mM N,N, N',N'-tetramethyl-p-
phenylenediamine (TMPD), 2 mM ascorbate, 8 μM reduced cyto-
chrome C [33]. ADP was made in a 100 × stock concentration of
200 mM in respiration medium; 10 μL were added to each chamber
for a ﬁnal concentration of 2 mM.
Adherent cells in culture in Neurobasal A/B27 were gently rinsed
with permeabilization medium two times before they were transferred
to the Oxygraph-2 k chambers containing 1 mL permeabilization
medium being stirred at 300 rpm. After a baseline respiration
measurement was obtained, 10 μL of 5 mg/mL saponin dissolved in
Fig. 1. Adult neurons were cultured on 15 mm2 glass cover slips and supported in the
respiration chamber by a silicone-topped teﬂon stir bar. (A) Neurons prepared from
middle-age rats cultured on a glass cover slip. (B) Neurons prepared from old rats
cultured on a glass cover slip. The ﬁelds pictured are 0.04 mm2. (C) Silicone-topped
teﬂon stir bar designed to support substrate-adherent neurons on a 15 -mm glass
culture slip while measuring oxygen consumption.
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concentration of 50 μg/mL. After 3 min of saponin permeabilization,
stirring was stopped. 800 μL of the ﬂuid in the chambers were removed
and replaced with 800 μL of respiration solution four times until only a
negligible amount (0.16%) of permeabilization solution remained.
Stirring resumed at 300 rpm and a basal respiration rate of permeabi-
lized cellswasmeasured before and after the addition of ADP. Inhibitors
were added as in non-permeabilized cells. Following each titration,
10 μMdiphenylene iodoniumwas added to determine the contribution
of NADPH oxidase to measured oxygen consumption [49,50].
2.4. Data analysis
Non-linear regression curves were ﬁt to the dose response data
using Plot-It software (Scientiﬁc Programming Enterprises, Haslett,
Michigan). IC50 values were derived algebraically from the non-
linear regression equations. Standard errors were generatedmanually
for these values using the coefﬁcient errors for each term generated
by Plot-It. Flux threshold plots were generated using the percent
inhibition of respiration by each inhibitor in neurons with excess
exogenous substrates as a function of the percent of initial respiration
remaining after the same dose of inhibitor applied to whole neurons
with endogenous substrates [51]. Flux thresholds were determined as
the point at which a change in inﬂuence of substrates on inhibition of
respiration occurred. Plot-It software was used to perform Student's
t-tests, linear regression, means and S.E.M.
3. Results
Fig. 1 illustrates healthy in situ neurons from (A) middle-age and
(B) old rats, as well as (C) the silicone-topped teﬂon stir bar and glass
culture slip on which neurons were cultured for measurement of
oxygen consumption. In a previous study in our laboratory, staining
for neuroﬁlament, GFAP, and Ox-42 indicated ∼80% neurons, 5%
astroglia, 10% oligodendroglia, and 5% microglia [52]. Neurons with
endogenous substrates were evaluated in culture medium (Neuroba-
salA/B27), to mimic the extracellular potassium concentration in the
brain. Neurons with excess exogenous substrates were permeabilized
with saponin andmeasured in a respirationmediumwith a potassium
concentration similar to intracellular levels.
3.1. Intact neurons with endogenous substrates
In Fig. 2, we measured selective inhibition of respiration in whole
neurons at rest in situ. To determine the age contribution of each
complex on oxygen consumption at complex IV, electron transport at
complexes I–IV was selectively inhibited. The percent of initial
respiration was plotted as a function of the inhibitor dose. The IC50
values were calculated to indicate the efﬁcacy of the inhibitor for each
complex (Table 2). In Fig. 2A, for neurons isolated from middle-age
rats, an IC50 of 1.4 μM for rotenone decreased 21% to 1.1 μM in
neurons isolated from old rats (p=0.005), indicating a decrease in
rotenone sensitivity of complex I in neurons isolated from old brains.
The IC50 value for respiratory inhibition by the complex II inhibitor, 3-
NP, showed an insigniﬁcant 49% increase from 5.7mM to 8.5 mMwith
age. For inhibition of complex III by antimycin A, the IC50 decreased
35%, from 0.24 μM to 0.16 μM with age (p=0.006). Finally, the IC50
value for KCN at complex IV decreased 33% from 18 μM to 12 μMwith
age (p= 0.002). These results reveal increased sensitivity to selective
inhibition in complexes I, III, and IV of neurons isolated from old rats
relative to those from young rats.
3.2. Neuronal permeabilization occurs in b3 min
To determine whether the effects of the inhibitors on neurons
with endogenous substrate levels were due to a substrate deﬁcit,we permeabilized neurons in situ and provided excess substrates
according to the method of Saﬁulina et al. [33]. They permeabi-
lized neurons with saponin for 15 min at 4 °C without affecting
mitochondrial membranes. In order to avoid cytoskeletal disas-
sembly [54], a pilot experiment showed that after just 3 min at
25 °C neurons were adequately permeabilized to allow propidium
iodide to enter (Fig. 3A). The time scale shows that after 15 min,
no new cells were stained relative to the 3-min time point,
simply the dye had become more dense as it collected within the
nuclei.
3.3. Old neurons respire at a higher rate than neurons prepared from
middle-age rats in pre-permeabilization medium
In preparation for permeabilization, neurons were transferred
from culture medium ([K+]= 5.4 mM) to a medium with a
depolarizing concentration of K+(142 mM), similar to the intracel-
lular potassium that is required for mitochondrial function. At
depolarizing K+, neurons were expected to respire at higher rates to
generate ATP to power the Na+/K+ATPase that keeps the plasma
Fig. 2.Non-permeabilized resting neurons in culture medium showed age-related differences between neurons prepared from old andmiddle-age rats only at complexes I, III and IV.
(A) Complex I by rotenone, Middle-age curve ﬁt: Y= 73.6×e−0.48X+ 23.2, Old: Y= 84.8×e−0.65X+ 15.0. (B) Complex II by 3-nitropropionic acid, Middle-age: Y= 99.4×e−0.11X-
3.2, Old: Y= 129×e−0.079X- 31.3. (C) Complex III by antimycin A Middle-age: Y= 61.0×e−2.75X+ 37.1, Old: Y= 75.1×e−4.4X+ 24.6. (D) Complex IV by KCN, Middle-age: Y=
67.1×e−0.038X+ 31.4, Old: Y= 83.6×e−0.058X+ 15.3. n= 4–6 culture slips. Panel D was derived from data published by Jones and Brewer, 2009. IC50 values were derived from
these data and summarized in Table 2.
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and substrate addition, neurons prepared from middle-age rats
respired at a rate 50% higher in this depolarizing medium than their
respiration rate in culture medium. Respiration of neurons prepared
from old rats increased by 180% in the pre-permeabilization medium
(Fig. 3B). The fact that respiration increasedmore in neurons prepared
from old rats than in neurons prepared from middle-age rats may
indicate that ATP production was less efﬁcient in the neurons
prepared from old rats in culture medium or that the neurons
prepared from old rats had less phosphocreatine reserve to make ATP
[55]. Following treatment with saponin for 3 min, respiration in the
neurons prepared from old rats ceased to be driven maximally as
cytoplasmic ADP and other substrates were diluted from the
cytoplasm by permeabilization. Respiration in neurons prepared
from middle-age rats decreased insigniﬁcantly, possibly due to a
greater phosphocreatine reserve [55].Table 2
IC50 of complex-speciﬁc inhibitors in cortical neurons from old and middle-age rats with a
IC50 Complex I (μM) Complex II (mM)
MA Old p MA Old
Endogenous Substrates 1.4 1.1 0.005 5.7 8.5
Exogenous Substrates 3.0 1.0 0.02 6.1 2.13.4. Neurons isolated from middle-age and old rats increase respiration
in response to substrate supplementation
In Fig. 4, oxygen consumption was measured in pre-permeabiliza-
tion medium prior to addition of any substrates to obtain a rate of non-
supplemented basal respiration. Following permeabilization and a
change to substrate-supplemented respiration medium, middle-age
neuron respirationwas signiﬁcantly increased at least two-fold for each
complex. Neurons prepared from old rats showed a signiﬁcant increase
in respiration in complexes I, III, and IV, and a trend toward increase for
complex II. Complex-speciﬁc substrate-supplemented respiration was
not, however, signiﬁcantly different between neurons prepared from
old and middle-age rats. This result indicates that, given adequate
substrates, neurons prepared from old rats were able to maintain a rate
of respiration comparable to neurons prepared from middle-age rats,
and that supply of substrate limited native respiration in old neurons.nd without excess endogenous substrates.
Complex III (μM) Complex IV (μM)
p MA Old p MA Old p
0.5 0.24 0.16 0.006 18 12 0.002
0.9 0.13 0.052 0.0001 33 26 0.5
Fig. 3. Neurons were adequately permeabilized after b3 min. (A) A healthy cell culture
exposed to propidium iodide and incubated with saponin for 0, 1, 3, and 15 min showed
that all cells were adequately permeabilized for substrate addition after 3 min. Phase
contrast images before saponin and after 15 min of treatment indicate integrity of the
permeabilized neurons seen by the intervening nuclear ﬂuorescence images. Scale is
100 μm. (B) Neuron respiration in culture medium (C) is not signiﬁcantly different
between old and neurons prepared from middle-age rats. (gray bars; [17]). In pre-
permeabilization medium (P), the rate of respiration in neurons prepared from old rats
was increased 50% over that in neurons prepared from middle-age rats prior to the
addition of saponin (center bars). Following addition of saponin, the rate of respiration in
neurons prepared frommiddle-age rats remained the same,while the rate of respiration in
neurons prepared fromold rats was reduced to the rate of neurons prepared frommiddle-
age rats (hatched bars). n= 13–24 culture slips, as indicated in graph. Before and after
pictures are phase contrast, time scale pictures are red ﬂuorescence.
Fig. 4. Rate of respiration increased when cells were given excess substrates. For
complexes I, I+II, and IV with the addition of excess substrates, respiration
signiﬁcantly increased over basal for both ages of neurons. However, no signiﬁcant
age-related differences were observed in basal respiration between middle-age (white
bars) and old (black bars) neurons when cells were given excess ADP and substrates for
each complex. n=6 culture slips of each age.
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excess substrates for upstream complexes
Fig. 4 shows that, in neurons prepared from middle-age rats given
artiﬁcial electron donors for complex IV, respiration was increased
1.8-fold higher than in neurons prepared from middle-age rats given
substrates for upstream complexes I and II. In neurons prepared from
old rats given artiﬁcial electron donors for complex IV, respirationwas
increased 2-fold higher than in neurons prepared from old rats given
substrates for complex I. These data suggest that complex IV itself, in
both ages, has reserve capacity to respond to excess electronavailability revealed by direct electron supply that is limited by
indirect supply through the Kreb's cycle. These observations imply
that a deﬁciency in energy production is more likely due to an
upstream electron deﬁciency that becomesmore severe with age than
to an enzymatic deﬁciency in complex IV quantity or function.
3.6. In permeabilized neurons from old rats with exogenous substrates,
complexes I and I+II are more susceptible to selective inhibition
relative to neurons from middle-age rats
In contrast to the in situ measurements of respiration with
endogenous substrates shown in Fig. 2, here we investigated with
excess substrates in permeabilized neurons in situ how respiration was
affectedwhen the individual complexeswere inhibited. This allowed us
to determine the role of substrate availability on the inhibition of
speciﬁc complexes in their native state. Fig. 5 illustrates the percent
inhibition of respiration for increasing doses of selective inhibitors.
Table 2 lists the IC50 values for each inhibitor to indicate the efﬁcacy of
inhibition for each complex. In Fig. 5A, for neurons isolated frommiddle-
age rats, an IC50 of 3.0 μM for rotenone decreased 67% to 1.0 μM in
neurons isolated from old rats (p=0.02), indicating an increase in
rotenone sensitivity of complex I in neurons isolated from old brains.
Since rotenone acts at the quinone oxidation site [53], this increased
sensitivity to rotenone may also indicate a deﬁciency of reduced
quinoneor the ability of the site to bind reducedquinone. The IC50 value
for respiratory inhibition by the complex II inhibitor, 3-NP, showed an
insigniﬁcant 66% decrease from 6.1 mM to 2.1 mM with age. For
inhibition of complex III by antimycin A, the IC50 decreased 60%, from
0.13 μM to 0.052 μM with age (p=0.0001). Finally, the IC50 value for
KCN at complex IV decreased 21% from 33 μM to 26 μM with age
(p= 0.5). These results reveal increased sensitivity to selective
inhibition in complexes I and I+II of permeabilized neurons isolated
from old rats relative to those from middle-age rats.
3.7. Comparisons of endogenous to exogenous excess substrates
Line wise comparisons in Table 2 suggest age-related differences
between responses to inhibitors for endogenous and exogenous
Fig. 5. Permeabilized resting neurons given excess exogenous substrates showed age-related differences in sensitivity to inhibition between neurons prepared from old and middle-
age rats at (A) complex I by rotenone, middle-age curve ﬁt Y=−84.7×e−0.23X+ 85.8; old curve ﬁt Y=−72.0×e−0.65X+ 74.4 (B) complex II by 3-nitropropionic acid, middle-age
curve ﬁt Y=−87.0×e−0.10X+ 93.2; old curve ﬁt Y=−52.8×e−0.22X+ 67.1 (C) complex III by antimycin A, middle-age curve ﬁt Y=−72.4×e−13.2X+ 72.7; old curve ﬁt Y=
−61.0×e−5.1X+ 63.7 and (D) complex IV by KCN, middle-age curve ﬁt Y=−48.6×e−0.020X+ 50.4; old curve ﬁt Y=−50.7×e−0.026X+ 52.0. n=5–6 culture slips. IC50 values
were derived from these data and summarized in Table 2.
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neurons isolated frommiddle-age rats with exogenous substrates, but
decreased 9% after addition of excess exogenous glutamate and
malate for neurons isolated from old rats. However, for complex II, the
IC50 of 3-NP increased by 7% in neurons isolated frommiddle-age rats
and decreased 75% in neurons isolated from old rats when complex I
was inhibited and the neurons were supplemented with excess
exogenous succinate. IC50 for antimycin A decreased 46% in neurons
isolated from middle-age rats supplemented with excess exogenous
glutamate, malate, and succinate, but in neurons isolated from old rats
the IC50 for antimycin A decreased 68% with the addition of these
excess exogenous substrates. Finally, the addition of excess exoge-
nous electron donors for complex IV, TMPD, cytochrome C, and
ascorbate, increased the IC50 of KCN by 83% in neurons isolated from
middle-age rats and by 117% in neurons isolated from old rats.
3.8. Flux control analysis of neurons with endogenous and excess
exogenous substrates
To assess the level of control each complex exerted over electron
transport, we compared respiratory ﬂux ratios at the same inhibitor
concentrations for neurons with endogenous and excess endogenous
substrates [51] (Fig. 6). At each individual complex, we plotted the
percent of initial respiration remaining at each dose of inhibitor as a
function of the percent inhibition of respiration in neurons with
excess exogenous substrates at the same dose. A slope of−1, plotted
for reference in Fig. 6, was expected if the complex and its substrates
exerted no control over global ﬂux. A more negative slope impliessubstrate limitation at that complex. Less complex capacity is
indicated by a lower intersection on the x-axis (complex reaches
maximal inhibition with endogenous substrate without reserve to
process the excess substrate). Through ﬂux analysis, we determined
which complexes were most limiting to electron transport, and
whether these limitations were due to substrate or enzyme
deﬁciencies (Table 3). The slope of the line after the ﬂux threshold
point determined whether the activity limitations were due to
substrate or enzyme deﬁciencies. A more negative slope beyond the
ﬂux point implied a substrate limitation in the endogenous state.
For complex I in neurons isolated from middle-age rats, a ﬂux
point occurred at 39% of initial respiration with endogenous
substrates (3 μM rotenone) with a slope increase from −1.5 to
−0.46. At this ﬂux point, respiration in neurons with endogenous
substrates was inhibited 61%, while respiration in neurons with
excess exogenous substrates was only inhibited 39%, suggesting an
endogenous NADH substrate limitation that could be partially
corrected by exogenous substrates. Extrapolation of the x-intercept
showed that some respiratory capacity would remain in neurons with
endogenous substrates given a rotenone dose that would completely
inhibit respiration in neurons with excess exogenous substrates. This
20% residual electron ﬂow in neurons with endogenous substrates is
likely due to other branches that feed CoQ to complex III, such as
complex II, fatty acid dehydrogenase, and glyceraldehyde 3-phos-
phate dehydrogenase. For neurons isolated from old rats, the data
suggest a ﬂux point at 40% of initial respiration with endogenous
substrates, but at 8 μM rotenone, where the slope increased from
−3.6 to −0.8. Therefore rotenone concentrations in excess of 8 μM
Fig. 6. Flux control point analysis for neurons with endogenous substrates and excess exogenous substrates compared at (A) complex I, (B) complex II, (C) complex III, and (D)
complex IV. The slopes of the linear regressions, x-intercepts, and ﬂux threshold points were summarized in Table 3.
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excess endogenous substrates. Furthermore, the extrapolated linear
regression for the ﬁrst two rotenone doses shows that rotenone that
would inhibit 31% of respiration in neurons with excess exogenous
substrates would not affect neurons with endogenous substrates. This
result may be due to membrane resistance against rotenone in non-
permeabilized neurons from old rats, or excess exogenous substrates
may uncover some additional rotenone-sensitive activity. The
extrapolated x-intercept was 96%, revealing complete inhibition of
respiration by inhibition at complex I enzyme activity in neurons
isolated from old rats given excess exogenous substrates.
For complex II, the data suggest that neurons isolated from
middle-age rats reached a ﬂux point at 39% of initial rate with
endogenous substrates (at) 8 mM 3-NP where the slope decreased
from −1.2 to −2.1. This increase in slope beyond the ﬂux pointTable 3
Slopes, substrate-supplemented capacity derived from ﬂux analysis, and the ﬂux threshold
Complex I Complex
MA Old p MA
Slope 1 −1.54 −3.58 0.001 −1.17
Slope 2 −0.46 −0.82 0.26 −2.13
Substrate-supplemented capacity 127% 96% 72%
Flux threshold (% endogenous, %exogenous) 39, 39 48, 40 40, 54indicated that endogenous substrates became rate-limiting. The
extrapolated x-intercept indicated that a concentration of 3-NP that
would completely inhibit activity in neurons from middle-age rats
with endogenous substrates would only inhibit respiration in neurons
with excess exogenous substrates by 72%, revealing a limitation in
complex II capacity. Neurons isolated from old rats did not show a
deﬁned ﬂux point, but the extrapolated linear regression for all doses
of 3-NP shows that a dose of 3-NP that would inhibit 28% of
respiration in neurons with excess exogenous substrates would not
affect neurons with endogenous substrates. This result may be due to
membrane resistance against 3-NP in non-permeabilized neurons
from old rats, or excess exogenous substrates may uncover some
additional 3-NP-sensitive activity. The extrapolated x-intercept
indicated that a concentration of 3-NP that would completely inhibit
respiration in neurons from old rats with endogenous substratess have been calculated from Fig. 6.
II Complex III Complex IV
Old p MA Old p MA Old p
−2.29 b0.001 −1.45 −1.27 0.03 −2.03 −2.76 0.1
N/A N/A N/A −0.83 −0.75 0.3
71% 111% 89% 60% 85%
28, 100 42, 100 10, 100 24, 51 28, 24
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substrates by 71%, revealing a capacity limitation in complex II in
neurons isolated from old rats similar to the limitation revealed in
neurons isolated from middle-age rats.
For complex III, neurons isolated from middle-age rats did not
reveal a distinct ﬂux point, however the extrapolated linear regression
for all doses of antimycin A showed that a dose of antimycin A that
would inhibit 42% of respiration in neurons with excess exogenous
substrates would not affect neurons with endogenous substrates. This
result may be due to membrane resistance against antimycin A in
non-permeabilized neurons from middle-age rats, or excess exoge-
nous substrates may uncover some additional antimycin A-sensitive
activity. The extrapolated x-intercept exceeding 100% indicated that a
dose of antimycin A which would completely inhibit respiration in
neurons with excess exogenous substrates would not completely
inhibit respiration in neurons with endogenous substrates. Again, this
may be due to membrane resistance in non-permeabilized neurons.
Neurons isolated from old rats also failed to reveal a distinct ﬂux
point, however the extrapolated linear regression for all doses of
antimycin A shows that a concentration of antimycin A that would
completely inhibit respiration in neurons from old rats with
endogenous substrates would only inhibit respiration in neurons
with excess exogenous substrates by 89%, revealing a limitation in
complex III capacity in neurons isolated from old rats.
For complex IV, neurons isolated from middle-age rats reached a
ﬂux point at 51% of initial respiration with endogenous respiration
(30 μM KCN) where the slope increased from −2.0 to −0.8.
Concentrations of KCN in excess of 30 μM more effectively inhibited
neurons from middle-age rats with excess exogenous substrates,
revealing a limitation in the capacity of complex IV that is not
corrected by substrate supplementation. The extrapolated x-intercept
indicated that a concentration of KCN that would completely inhibit
activity in neurons from middle-age rats with endogenous substrates
would only inhibit respiration in neurons with excess exogenous
substrates by 85%, reinforcing that complex IV capacity is limited.
Neurons isolated from old rats did not reach a ﬂux point until 25% of
initial respiration with endogenous respiration (0.1 μM KCN) where
the slope increased from −2.8 to −0.8. Concentrations of KCN up to
30 μM more effectively inhibited neurons from old rats with
endogenous substrates, revealing a limitation in the capacity of
complex IV in neurons from old rats that is greater than the limitation
in neurons from middle-age rats. This difference is marked by an
extrapolated x-intercept of 60% inhibition of respiration with excess
substrates for neurons isolated from old rats compared to only 85%
inhibition for neurons frommiddle-age rats, at concentrations of KCN
that would completely inhibit activity in neurons with endogenous
substrates.
4. Discussion
In a previous study, we discovered that intact, substrate-adherent
neurons prepared from old rats in culture medium exhibit no
difference in basal respiration relative to neurons prepared from
middle-age rats, but do exhibit a decreased capacity to upregulate
respiration in response to glutamate stimulation [17]. We also
observed a deﬁcit in Complex IV activity in neurons prepared from
old rats with endogenous substrate levels that could be corrected in
submitochondrial particles with addition of an artiﬁcial electron
donor. Here, we tested substrate supplementation in complex IV in
neurons in situ to conﬁrm the effect of substrate supplementation in
whole neurons as a less perturbed condition than submitochondrial
particles. We found age-related changes in IC50 for complexes I, III
and IV in neurons in situ with endogenous substrates. In situ neurons
with excess exogenous substrates exhibited heightened sensitivity to
inhibitors at complexes I and III. Thus, the age-related inhibition at
complex IV was relieved by excess substrate, suggesting that complexIV was substrate-limited in the native state in neurons isolated from
old rats. Furthermore, the common age-related differences at
complexes I and III suggest an inherent deﬁcit in these complexes in
neurons isolated from old brains that can't be overcome completely
with excess substrate.
4.1. Limitations of the study
In research performed prior to this study, enzyme complexes have
been assayed directly for activity to generate ﬂux control coefﬁcients
[51]. Due to the nature of our sample, which contained substrate-
adherent neurons per cover slip of 37,700±4200 (middle-age,
n=44) or 33,390±4100 (old, n=37; p=0.47), accurate assays of
individual enzyme complexes were not possible. Therefore we
alternatively chose to compare respiration in neurons with endoge-
nous substrates to respiration in neurons given excess endogenous
substrates. In this way, we were able to observe whether deﬁciencies
in respiration in neurons from middle-age and old rat neurons were
corrected by substrate supplementation. Furthermore, in hindsight, a
lower concentration range for the complex-speciﬁc mitochondrial
inhibitors may reveal further differences in neuronal response,
especially for complexes I and III. This observation requires some
reservations in the conclusions about these complexes.
Flux analysis revealed signiﬁcant age-related changes for each of
the complexes I, II, III and IV. The largest change in sensitivity to
substrate availability as indicated by the most negative initial slope of
the ﬂux curves occurred with complex I for neurons isolated from old
rats. These results are consistent with the ﬁnding that endogenous
NADH is limited in neurons isolated from old rats [12]. For neurons
isolated frommiddle-age rats, the initial slopesmaintained a balanced
range from −1.2 to −2.0 for complexes I–IV, with complex IV
exerting the greatest ﬂux control.
Flux analysis also revealed age-related limits in capacity, as
indicated by lower x-intercepts of the ﬂux curves. For complex I,
neurons with endogenous substrates from middle-age rats had the
ability to compensate for inhibition of electron ﬂow through complex
I, possibly via complex II, glyceraldehyde-3-phosphate dehydroge-
nase, or fatty acid dehydrogenase. Neurons from old rats did not have
the same compensatory capability, and with excess substrates in fact
were inhibited more by low concentrations of rotenone than neurons
from middle-age rats. Because rotenone binds at the quinone
oxidation site [56], these results may indicate an age-related
alteration in the ability of the neuron to bind coenzyme Q, limiting
its energy-producing capacity. The same greater sensitivity of neurons
from old rats with endogenous substrates was observed for inhibition
at complex II, which also requires reduced coenzyme Q as a substrate.
Age-related alteration of complex I is not a new concept in the ﬁeld
of neurodegeneration. Rotenone toxicity is an accepted model of
Parkinson's disease (PD), implicating complex I deﬁciency in the
neurodegeneration that occurs in PD [57,58]. Our complex I results
support previous proposals that complex I is deﬁcient in its ability to
transfer electrons to the quinone pool in aged neurons [59]. Complex I
deﬁciency in the substantia nigra is widely accepted as a possible
cause of PD [60], so these results with aged neurons from the
mammalian cortex, a selectively vulnerable region in Alzheimer's
disease (AD), suggest that complex I deﬁciency with age and
speciﬁcally in the oxidized quinone pool may in part contribute to
the aging requirement for neurodegeneration observed in AD [61–63]
and PD [63].
In complex III, neurons from middle-age rats not only were
resistant to inhibition by antimycin A, they also had a compensatory
protection against complete antimycin A inhibition in the endogenous
state. Neurons from old rats, however, were signiﬁcantly less resistant
to inhibition by antimycin A in the endogenous state and had a limited
capacity to respond to excess exogenous substrates. Since antimycin A
binds to complex III at the quinone reduction site [53], it is possible
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previously discussed are responsible for the limited capacity of
complex III to respond to excess electron ﬂow from excess substrates
provided to complexes I+II. Age-related irregularities in the quinone
pool could lead to generation of ROS [64], redox imbalance [20], and
catastrophic decline in energy production in the neuron [2]. In fact,
Rodriguez-Hernandez et al. [65] recently reported stimulation of
mitophagy, and consequently mitochondrial degradation, in patients
with coenzyme Q deﬁciency. Coenzyme Q10 has been shown to be
rate-limiting in the electron transport chain in beef heart mitochon-
dria [66], so an age-related decrease in content would have a large
effect. Coenzyme Q10 is also a scavenger of superoxide, so the
hypothesis of its deﬁciency lends to the abundant evidence that
excess ROS plays a role in neurodegeneration with age [67,68].
However, the parallel generation of ROS and decline in mitochondrial
membrane potential observed in old neurons, and the higher starting
ROS and depolarized mitochondrial membrane potential [64] suggest
another factor such as redox potential [12] may be upstream and
impact all mitochondrial function.
Complex IV was inhibited much more effectively in neurons from
old rats with endogenous substrates given low doses of inhibitor than
in neurons from middle-age rats with endogenous substrates,
indicating an age-related limitation in electron ﬂow to complex IV.
This ﬁnding was not surprising, given the age-related deﬁcits in
electron transport in upstream complexes, and supported our
previous ﬁnding that complex IV is substrate-limited in neurons
from old rats [17]. One possible explanation for the increased
inhibition in neurons prepared from old rats with endogenous
substrates is the accumulation of nitric oxide (NO), also an inhibitor
of complex IV, which attenuates inhibition of complex IV activity by
potassium cyanide in brain mitochondria [69,70]. Furthermore,
Clementi et al. [78] have shown that prolonged exposure of
mitochondria to NO also leads to inhibition of complex I. It is possible
that prolonged generation of NO may also damage complex I in
mitochondria over time, resulting in an age-related decline in electron
ﬂow to complex IV.
The most signiﬁcant age-related deﬁcit in capacity to respond to
excess substrates was measured at complex IV, responding 29% less in
neurons from old rats (60%) than in neurons from middle-age rats
(85%). As opposed to the submitochondrial particles we previously
studied, complex IV in neurons in situ had an age-related enzymatic
deﬁcit when given excess exogenous substrates. The stress of the
particle isolation possibly damaged mitochondria from middle-age
rats, bringing their activity down to the level of mitochondria from old
rats. Furthermore, in intact neurons the age-related cardiolipin
damage we observed previously [17] limits electron transport.
In addition to the conclusions derived for each individual complex,
we can make conclusions based on this study regarding the overall
bioenergetic status of aging rat brain mitochondria. The deﬁcits we
observed in complexes I and III are of additional signiﬁcance because
they are considered the main producers of ROS in the mitochondrion
[72,73]. Interestingly, in 30-month rat brain synaptosomes relative to
4-month rat brain synaptosomes, Curti et al. [74] found deﬁcits in
complex IV using cytochrome C as substrate. Since we also found age-
related deﬁcits in complex IV inhibition by KCN, complex IV appears
to accumulate damage at multiple sites with age. Similar to our results
in whole neurons with endogenous substrates, Navarro et al. [75]
found in isolated cortical mitochondria no age-related deﬁcits in basal
respiration supplemented with glutamate/malate or succinate.
The age-related substrate deﬁcits in neurons isolated from the
aging brain environment that persist in culture independent of aging
hormone levels, vasculature, and immune system could be explained
by epigenetic control of metabolism, as has been observed in aging
human skeletal muscle [76,77]. Our cumulative evidence suggests
depleted coenzyme Q levels between complexes I and III. Past clinical
trials showed that oral coenzyme Q10 supplementation at a dose of3 mg/kg body weight in human subjects with no known diseases
increased plasma concentrations of coenzymeQ10measured by HPLC,
increased platelet levels, and delayed formation of 8-hydroxydeoxy-
guanosine [78]. Others have shown healing effects of oral coenzyme
Q10 in patients with mitochondrial diseases such as MELAS [80–81].
Our studies add to the growing body of evidence that dysfunction in
the enzyme complexes of the electron transport chain with age lend
to age-related neurodegeneration in senescence-related diseases. Our
experiments here and previously [12] support an age-related lack of
endogenous substrates or a failure of upstream complexes to
transport electrons to complex IV, ultimately leading to age-related
neurodegeneration [2].
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